Asia-Pacific Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type of Packaging, Type of Delivery, Indication, and End User

List of Tables

The APAC lyophilized injectable market is expected to grow from US$ 673.33 million in 2022 to US$ 996.85 million by 2028. It is estimated to grow at a CAGR of 6.8% from 2022 to 2028.

Advancement in Lyophilized Packaging

The complexity of drug reconstitution constrained the market potential for lyophilized drugs and vaccines. Multiple pieces of device and long procedures are required to reconstitute a lyophilized drug from a vial; thus, most of these products are restricted within healthcare facilities. However, the healthcare transformation toward patient self-injection and the acceleration after biologics flared a new wave of creation for drug reconstitution technology. Dual-chamber syringes represent an enabling technology for the self-injection of lyophilized drugs and new therapies directing the mixing of two liquid molecules at the time of drug delivery. Prefilled dual chamber devices (DCDs) are combination devices containing freeze-dried drugs and diluent in two separate chambers of the device. DCDs have shown many advantages, such as easy handling, accurate dosing, seal integrity, and high stability, compared to the traditional drug-delivery systems; therefore, they are promising alternatives to these traditional drug-delivery systems. DCDs are being increasingly preferred by physicians for patients needing instant relief and safe delivery, significantly improving drug delivery by quickly applying pressure to the end plunger after mixing and dissolving freeze-dried powder. DCDs can improve long-term pharmaceutical stability by storing them in the lyophilized form before administration and therefore are becoming more popular, especially for those unstable pharmaceutical products. Therefore, advancement in lyophilized packaging is expected to drive the market across the region.

Market Overview

The APAC lyophilized injectable market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022. The market's growth is primarily attributed to the established pharmaceutical market, increased R&D expenditures by pharmaceutical and biopharmaceutical companies, and favorable regulatory policies. The excessive population in China and the rise of various communicable and noncommunicable diseases are majorly driving the pharmaceutical companies in China, making it a prime market in Asia Pacific. For instance, the COVID-19 outbreak in China led to the launch of several drugs to counter the virus. It increased contract manufacturing of drugs, such as lyophilized remdesivir powder, fueling the demand for lyophilized injectables in the country. Due to the pandemic, various market players ramped up the production of certain lyophilized drugs as it ensures safe and prolonged packaging of the drugs. Market players in China have constantly been evolving with organic and inorganic strategies. For instance, WuXi STA-a subsidiary of WuXi AppTec-announced its first parenteral formulation production line at the Wuxi city site. This wholly automatic sterile manufacturing line runs in a complete isolation system with an annual capacity of 2 million units. The automatic parenteral filling line features numerous filling modules and a built-in lyophilizer to fill syringes, vials, and cartridges of a full range of sizes and produce lyophilized powders. Thus, growing pharmaceutical & biopharmaceutical market and increasing initiatives by market players are expected to drive the market during the forecast period.

APAC Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)

APAC Lyophilized Injectable Market Segmentation

The APAC lyophilized injectable market is segmented based on type of packaging, type of delivery, indication, end user, and country.

Based on type of packaging, the APAC lyophilized injectable market is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. The single-use vials segment held the largest market share in 2022. In terms of type of delivery, the APAC lyophilized injectable market is categorized into prefilled diluent syringes, single-step devices, proprietary reconstitution devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2022. Based on indication, the APAC lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and others. The metabolic and oncology conditions segment held the largest market share in 2022. Based on end user, the APAC lyophilized injectable market is categorized into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2022. Based on country, the APAC lyophilized injectable market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022.

Aristopharma Ltd.; Baxter; CordenPharma International; Credence MedSystems, Inc.; Curia Global, Inc.; Jubilant HollisterStier (Jubilant Pharma Limited); Nipro; Recipharm AB; S.G. Biopharm Pvt. Ltd.; and Vetter Pharma are among the leading companies operating in the APAC lyophilized injectable market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC lyophilized injectable market.
Highlights key business priorities to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC lyophilized injectable market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the lyophilized injectable market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00027577

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 APAC Lyophilized Injectable Market - By Type of Packaging
- 1.3.2 APAC Lyophilized Injectable Market - By Type of Delivery
- 1.3.3 APAC Lyophilized Injectable Market - By Indication
- 1.3.4 APAC Lyophilized Injectable Market - By End User
- 1.3.5 APAC Lyophilized Injectable Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. APAC Lyophilized Injectable Market - Market Landscape

4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion

5. APAC Lyophilized Injectable Market- Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Demand for Contract Research Manufacturing Services
- 5.1.2 Increasing Demand of Biologics
5.2 Market Restraints
- 5.2.1 Product Recalls
5.3 Market Opportunities
- 5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
5.4 Future Trends
- 5.4.1 Advancement in Lyophilized Packaging
5.5 Impact Analysis

6. Lyophilized Injectable Market- APAC Analysis

6.1 APAC Lyophilized Injectable Market Revenue Forecast and Analysis

7. APAC Lyophilized Injectable Market Analysis - By Type of Packaging

7.1 Overview
7.2 APAC Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
7.3 Single-use vials
- 7.3.1 Overview
- 7.3.2 Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Point-of-Care Reconstitution
- 7.4.1 Overview
- 7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Specialty Packaging
- 7.5.1 Overview
- 7.5.2 Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

8. APAC Lyophilized Injectable Market Analysis - By Type of Delivery

8.1 Overview
8.2 APAC Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
8.3 Prefilled Diluent Syringes
- 8.3.1 Overview
- 8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Single Step Devices
- 8.4.1 Overview
- 8.4.2 Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Proprietary Reconstitution Devices
- 8.5.1 Overview
- 8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Multi-Step Devices
- 8.6.1 Overview
- 8.6.2 Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

9. APAC Lyophilized Injectable Market Analysis - By Indication

9.1 Overview
9.2 APAC Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
9.3 Metabolic and Oncology Conditions
- 9.3.1 Overview
- 9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
- 9.4.1 Overview
- 9.4.2 Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Autoimmune Diseases
- 9.5.1 Overview
- 9.5.2 Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Indications
- 9.6.1 Overview
- 9.6.2 Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

10. APAC Lyophilized Injectable Market Analysis - By End User

10.1 Overview
10.2 APAC Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
- 10.5.1 Overview
- 10.5.2 Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
- 10.6.1 Overview
- 10.6.2 Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

11. APAC Lyophilized Injectable Market - Country Analysis

11.1 Overview
- 11.1.1 APAC: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  - 11.1.1.1 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.1.1 Overview
    - 11.1.1.1.2 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.1.3 China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.1.1.1.4 China: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.1.1.5 China: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.1.1.6 China: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.1.1.2 India Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.2.1 Overview
    - 11.1.1.2.2 India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.2.3 India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.1.1.2.4 India: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.1.2.5 India: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.1.2.6 India: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.1.1.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.3.1 Overview
    - 11.1.1.3.2 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.3.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.1.1.3.4 Japan: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.1.3.5 Japan: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.1.3.6 Japan: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.1.1.4 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.4.1 Overview
    - 11.1.1.4.2 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.4.3 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.1.1.4.4 South Korea: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.1.4.5 South Korea: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.1.4.6 South Korea: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.1.1.5 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.5.1 Overview
    - 11.1.1.5.2 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.1.1.5.3 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.1.1.5.4 Australia: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.1.5.5 Australia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.1.5.6 Australia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.1.1.6 Rest of APAC: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.6.1 Overview
    - 11.1.1.6.2 Rest of APAC: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.6.3 Rest of APAC: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.1.1.6.4 Rest of APAC: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.1.6.5 Rest of APAC: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.1.6.6 Rest of APAC: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Inorganic Growth Strategies
- 12.2.1 Overview
12.3 Organic Growth Strategies
- 12.3.1 Overview

13. Company Profiles

13.1 Baxter
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Nipro
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Curia Global, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Recipharm AB
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Vetter Pharma
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Jubilant HollisterStier (Jubilant Pharma Limited)
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Aristopharma Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 CordenPharma International
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Credence MedSystems, Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 S.G. Biopharm Pvt. Ltd.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms